blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2190304

EP2190304 - NUTRITIONAL FORMULATION WITH HIGH ENERGY CONTENT [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  20.11.2015
Database last updated on 06.07.2024
Most recent event   Tooltip08.01.2016Lapse of the patent in a contracting state
New state(s): CH, LI		published on 10.02.2016  [2016/06]
Applicant(s)For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
[N/P]
Former [2010/22]For all designated states
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Inventor(s)01 / HOIJER, Maarten Anne
G.A. van Nispenstraat 7
NL-6814 JA Arnhem / NL
02 / SIJBEN, Johannes Wilhelmus Christina
Lawickse Allee 106
NL-6707 AN Wageningen / NL
 [2010/22]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2013/28]
Former [2011/49]Swinkels, Bart Willem
Nederlandsch Octrooibureau J. W. Frisolaan 13
2517 JS Den Haag / NL
Former [2010/22]Swinkels, Bart Willem
Nederlandsch Octrooibureau J. W. Frisolaan 13
2517 JS Den Haag / NL
Application number, filing date08831921.517.09.2008
[2010/22]
WO2008NL50607
Priority number, dateWO2007NL0023017.09.2007         Original published format: PCT/NL2007/000230
[2010/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009038458
Date:26.03.2009
Language:EN
[2009/13]
Type: A1 Application with search report 
No.:EP2190304
Date:02.06.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 26.03.2009 takes the place of the publication of the European patent application.
[2010/22]
Type: B1 Patent specification 
No.:EP2190304
Date:07.12.2011
Language:EN
[2011/49]
Search report(s)International search report - published on:EP26.03.2009
ClassificationIPC:A23L1/29, A23L1/30, A61K38/00
[2010/22]
CPC:
A23L33/21 (EP,US); A23L33/115 (EP,US); A23L33/12 (EP,US);
A23L33/13 (EP,US); A23L33/17 (EP,US); A23L33/19 (EP,US);
A23L33/40 (EP,US); A61P3/02 (EP); A23V2002/00 (EP,CN,US) (-)
C-Set:
A23V2002/00, A23V2250/54, A23V2250/1882, A23V2200/33, A23V2250/51, A23V2250/50, A23V2200/308, A23V2200/302, A23V2200/326 (CN,EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/22]
TitleGerman:ERNÄHRUNGSFORMULIERUNG MIT HOHEM ENERGETISCHEN GEHALT[2010/22]
English:NUTRITIONAL FORMULATION WITH HIGH ENERGY CONTENT[2010/22]
French:FORMULATION NUTRITIONNELLE RICHE EN ÉNERGIE[2011/26]
Former [2010/22]FORMULATION NUTRITIONNELLE RICHES EN ÉNERGIE
Entry into regional phase17.03.2010National basic fee paid 
17.03.2010Designation fee(s) paid 
17.03.2010Examination fee paid 
Examination procedure16.07.2009Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.03.2010Examination requested  [2010/22]
30.03.2010Amendment by applicant (claims and/or description)
04.04.2011Despatch of a communication from the examining division (Time limit: M04)
21.04.2011Reply to a communication from the examining division
21.09.2011Communication of intention to grant the patent
26.10.2011Fee for grant paid
26.10.2011Fee for publishing/printing paid
Divisional application(s)EP11192130.0  / EP2428125
EP17171310.0  / EP3263120
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.04.2011
Opposition(s)Opponent(s)01  31.08.2012  18.10.2012  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
61352 Bad Homburg / DE
Opponent's representative
Heimann, Axel Colin
Fresenius Kabi Deutschland GmbH
Patent Department
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
 02  05.09.2012  18.10.2012  ADMISSIBLE
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park IL 60064 / US
Opponent's representative
Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
 03  07.09.2012  18.10.2012  ADMISSIBLE
Nestec S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Rupp, Christian
Mitscherlich PartmbB
Patent- und Rechtsanwälte
Karlstraße 7
80333 München / DE
 [N/P]
Former [2014/04]
Opponent(s)01  31.08.2012  18.10.2012  ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
61352 Bad Homburg / DE
Opponent's representative
Heimann, Axel Colin
Fresenius Kabi Deutschland GmbH
Patent Department
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
 02  05.09.2012  18.10.2012  ADMISSIBLE
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064 / US
Opponent's representative
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
 03  07.09.2012  18.10.2012  ADMISSIBLE
Nestec S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Rupp, Christian
Mitscherlich & Partner
Patent- und Rechtsanwälte
Sonnenstraße 33
80331 München / DE
Former [2012/42]
Opponent(s)01  31.08.2012    ADMISSIBLE
Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
61352 Bad Homburg / DE
Opponent's representative
Heimann, Axel Colin
Fresenius Kabi Deutschland GmbH
Patent Department
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
 02  05.09.2012   
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064 / US
Opponent's representative
Hayes, Adrian Chetwynd
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
 03  07.09.2012   
Nestec S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Rupp, Christian
Mitscherlich & Partner Patent- und Rechtsanwälte Sonnenstraße 33
80331 München / DE
Former [2012/41]
Opponent(s)01  31.08.2012   
Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
61352 Bad Homburg / DE
Opponent's representative
Heimann, Axel Colin
Fresenius Kabi Deutschland GmbH
Patent Department
Else-Kröner-Strasse 1
61352 Bad Homburg / DE
 02  05.09.2012   
Abbott Laboratories
100 Abbott Park Rd.
Abbott Park, IL 60064 / US
Opponent's representative
Hayes, Adrian Chetwynd
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
25.10.2012Invitation to proprietor to file observations on the notice of opposition
13.02.2014Despatch of communication that the patent will be revoked
21.07.2015Legal effect of revocation of patent [2015/52]
Appeal following opposition31.03.2014Appeal received No.  T0784/14
23.06.2014Statement of grounds filed
21.07.2015Result of appeal procedure: appeal of the proprietor was rejected
21.07.2015Date of oral proceedings
27.07.2015Minutes of the oral proceedings despatched
Fees paidRenewal fee
31.08.2010Renewal fee patent year 03
31.08.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.09.2008
CH07.12.2011
CY07.12.2011
CZ07.12.2011
EE07.12.2011
FI07.12.2011
HR07.12.2011
LI07.12.2011
LT07.12.2011
LV07.12.2011
MT07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
LU17.09.2012
MC30.09.2012
[2016/06]
Former [2014/34]HU17.09.2008
CY07.12.2011
CZ07.12.2011
EE07.12.2011
FI07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
MT07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
LU17.09.2012
MC30.09.2012
Former [2014/27]CY07.12.2011
CZ07.12.2011
EE07.12.2011
FI07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
MT07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
LU17.09.2012
MC30.09.2012
Former [2013/51]CY07.12.2011
CZ07.12.2011
EE07.12.2011
FI07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
MT07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
MC30.09.2012
Former [2013/29]CY07.12.2011
CZ07.12.2011
EE07.12.2011
FI07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
MC30.09.2012
Former [2012/36]CY07.12.2011
CZ07.12.2011
EE07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
RO07.12.2011
SK07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
Former [2012/35]CY07.12.2011
CZ07.12.2011
EE07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
BG07.03.2012
GR08.03.2012
IS07.04.2012
Former [2012/34]CY07.12.2011
CZ07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
GR08.03.2012
IS07.04.2012
Former [2012/28]CY07.12.2011
HR07.12.2011
LT07.12.2011
LV07.12.2011
GR08.03.2012
Former [2012/27]HR07.12.2011
LT07.12.2011
LV07.12.2011
GR08.03.2012
Former [2012/24]LT07.12.2011
LV07.12.2011
GR08.03.2012
Former [2012/20]LT07.12.2011
Cited inInternational search[A]WO0239978  (FRESENIUS KABI DE GMBH [DE], et al) [A] 1-6 * page 9, line 23 - page 13, line 3; example 2; claims 1,9-11,17-25 *;
 [A]WO2004032651  (WYETH CORP [US], et al) [A] 1-6 * the whole document *;
 [A]WO2004093557  (BRISTOL MYERS SQUIBB CO [US], et al) [A] 1-6 * paragraph [0025]; claims 1,5,8; table 1 *;
 [A]EP1634599  (NUTRICIA NV [NL]) [A] 1-6* the whole document *;
 [XD]WO2006091103  (NUTRICIA NV [NL], et al) [XD] 1,3-5 * page 3, line 1 - line 22 * * page 5, line 7 - page 10, line 14 * * page 12, line 1 - page 13, line 27 * * page 13, line 28 - page 14, line 22; example 3; claims 1,9-11,13,15-17 *;
 [XD]WO2007046699  (NUTRICIA NV [NL], et al) [XD] 1,3-6 * page 3, line 21 - page 10, line 21 * * page 11, line 27 - page 13, line 21; example 6; claims 1-7,9-13,15 *;
 [XD]WO2007073193  (NUTRICIA NV [NL], et al) [XD] 1,3-5 * page 4, line 1 - line 30 * * page 14, line 5 - page 15, line 33 * * page 16, line 12 - page 18, line 34; example 4; claims 1,3,5-7,10-16 *;
 [XP]WO2008005869  (ABBOTT LAB [US], et al) [XP] 1-5 * page 45, line 23 - line 30; examples 1-4; claims 1,6,15,21,29,30; table 1 *;
 [XP]WO2008048094  (NUTRICIA NV [NL], et al) [XP] 1-5 * claims 1,2,5-9,11-14 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.